A systematic analysis of natural α-glucosidase inhibitors from flavonoids of Radix scutellariae using ultrafiltration UPLC-TripleTOF-MS/MS and network pharmacology

Abstract Background Flavonoids from plant medicines are supposed to be viable alternatives for the treatment of type 2 diabetes (T2D) as less toxicity and side effects. Radix scutellariae (RS) is a widely used traditional medicine in Asia. It has shown great potential in the research of T2D. However...

Full description

Bibliographic Details
Main Authors: Le Wang, Nana Tan, Huan Wang, Jingbo Hu, Wenbo Diwu, Xiaoling Wang
Format: Article
Language:English
Published: BMC 2020-03-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12906-020-2871-3
_version_ 1828388329170665472
author Le Wang
Nana Tan
Huan Wang
Jingbo Hu
Wenbo Diwu
Xiaoling Wang
author_facet Le Wang
Nana Tan
Huan Wang
Jingbo Hu
Wenbo Diwu
Xiaoling Wang
author_sort Le Wang
collection DOAJ
description Abstract Background Flavonoids from plant medicines are supposed to be viable alternatives for the treatment of type 2 diabetes (T2D) as less toxicity and side effects. Radix scutellariae (RS) is a widely used traditional medicine in Asia. It has shown great potential in the research of T2D. However, the pharmacological actions remain obscured due to the complex chemical nature of plant medicines. Methods In the present study, a systematic method combining ultrafiltration UPLC-TripleTOF-MS/MS and network pharmacology was developed to screen α-glucosidase inhibitors from flavonoids of RS, and explore the underlying mechanism for the treatment of T2D. Results The n-butanol part of ethanol extract from RS showed a strong α-glucosidase inhibition activity (90.55%, IC50 0.551 mg/mL) against positive control acarbose (90.59%, IC50 1.079 mg/mL). A total of 32 kinds of flavonoids were identified from the extract, and their ESI-MS/MS behaviors were elucidated. Thirteen compounds were screened as α-glucosidase inhibitors, including viscidulin III, 2′,3,5,6′,7-pentahydroxyflavanone, and so on. A compound-target-pathway (CTP) network was constructed by integrating these α-glucosidase inhibitors, target proteins, and related pathways. This network exhibited an uneven distribution and approximate scale-free property. Chrysin (k = 87), 5,8,2′-trihydroxy-7-methoxyflavone (k = 21) and wogonin (k = 20) were selected as the main active constituents with much higher degree values. A protein-protein interaction (PPI) weighted network was built for target proteins of these α-glucosidase inhibitors and drug targets of T2D. PPARG (C d  = 0.165, C b  = 0.232, C c  = 0.401), ACACB (C d  = 0.155, C b  = 0.184, C c  = 0.318), NFKB1 (C d  = 0.233, C b  = 0.161, C c  = 0.431), and PGH2 (C d  = 0.194, C b  = 0.157, C c  = 0.427) exhibited as key targets with the highest scores of centrality indices. Furthermore, a core subnetwork was extracted from the CTP and PPI weighted network. Type II diabetes mellitus (hsa04930) and PPAR signaling pathway (hsa03320) were confirmed as the critical pathways. Conclusions These results improved current understanding of natural flavonoids on the treatment of T2D. The combination of ultrafiltration UPLC-TripleTOF-MS/MS and network pharmacology provides a novel strategy for the research of plant medicines and complex diseases.
first_indexed 2024-12-10T06:11:09Z
format Article
id doaj.art-7ad821b755cb445c92961d8a86991b3f
institution Directory Open Access Journal
issn 2662-7671
language English
last_indexed 2024-12-10T06:11:09Z
publishDate 2020-03-01
publisher BMC
record_format Article
series BMC Complementary Medicine and Therapies
spelling doaj.art-7ad821b755cb445c92961d8a86991b3f2022-12-22T01:59:33ZengBMCBMC Complementary Medicine and Therapies2662-76712020-03-0120111710.1186/s12906-020-2871-3A systematic analysis of natural α-glucosidase inhibitors from flavonoids of Radix scutellariae using ultrafiltration UPLC-TripleTOF-MS/MS and network pharmacologyLe Wang0Nana Tan1Huan Wang2Jingbo Hu3Wenbo Diwu4Xiaoling Wang5Shaanxi Key Laboratory of Phytochemistry, College of Chemistry and Chemical Engineering, Baoji University of Arts and SciencesShaanxi Key Laboratory of Phytochemistry, College of Chemistry and Chemical Engineering, Baoji University of Arts and SciencesCollege of Computer Science and Technology, Baoji University of Arts and SciencesCollege of Electronic and Electrical Engineering, Baoji University of Arts and SciencesShaanxi Key Laboratory of Phytochemistry, College of Chemistry and Chemical Engineering, Baoji University of Arts and SciencesShaanxi Key Laboratory of Phytochemistry, College of Chemistry and Chemical Engineering, Baoji University of Arts and SciencesAbstract Background Flavonoids from plant medicines are supposed to be viable alternatives for the treatment of type 2 diabetes (T2D) as less toxicity and side effects. Radix scutellariae (RS) is a widely used traditional medicine in Asia. It has shown great potential in the research of T2D. However, the pharmacological actions remain obscured due to the complex chemical nature of plant medicines. Methods In the present study, a systematic method combining ultrafiltration UPLC-TripleTOF-MS/MS and network pharmacology was developed to screen α-glucosidase inhibitors from flavonoids of RS, and explore the underlying mechanism for the treatment of T2D. Results The n-butanol part of ethanol extract from RS showed a strong α-glucosidase inhibition activity (90.55%, IC50 0.551 mg/mL) against positive control acarbose (90.59%, IC50 1.079 mg/mL). A total of 32 kinds of flavonoids were identified from the extract, and their ESI-MS/MS behaviors were elucidated. Thirteen compounds were screened as α-glucosidase inhibitors, including viscidulin III, 2′,3,5,6′,7-pentahydroxyflavanone, and so on. A compound-target-pathway (CTP) network was constructed by integrating these α-glucosidase inhibitors, target proteins, and related pathways. This network exhibited an uneven distribution and approximate scale-free property. Chrysin (k = 87), 5,8,2′-trihydroxy-7-methoxyflavone (k = 21) and wogonin (k = 20) were selected as the main active constituents with much higher degree values. A protein-protein interaction (PPI) weighted network was built for target proteins of these α-glucosidase inhibitors and drug targets of T2D. PPARG (C d  = 0.165, C b  = 0.232, C c  = 0.401), ACACB (C d  = 0.155, C b  = 0.184, C c  = 0.318), NFKB1 (C d  = 0.233, C b  = 0.161, C c  = 0.431), and PGH2 (C d  = 0.194, C b  = 0.157, C c  = 0.427) exhibited as key targets with the highest scores of centrality indices. Furthermore, a core subnetwork was extracted from the CTP and PPI weighted network. Type II diabetes mellitus (hsa04930) and PPAR signaling pathway (hsa03320) were confirmed as the critical pathways. Conclusions These results improved current understanding of natural flavonoids on the treatment of T2D. The combination of ultrafiltration UPLC-TripleTOF-MS/MS and network pharmacology provides a novel strategy for the research of plant medicines and complex diseases.http://link.springer.com/article/10.1186/s12906-020-2871-3Radix scutellariaeFlavonoidsα-Glucosidase inhibitorsUltrafiltrationLC-MSNetwork pharmacology
spellingShingle Le Wang
Nana Tan
Huan Wang
Jingbo Hu
Wenbo Diwu
Xiaoling Wang
A systematic analysis of natural α-glucosidase inhibitors from flavonoids of Radix scutellariae using ultrafiltration UPLC-TripleTOF-MS/MS and network pharmacology
BMC Complementary Medicine and Therapies
Radix scutellariae
Flavonoids
α-Glucosidase inhibitors
Ultrafiltration
LC-MS
Network pharmacology
title A systematic analysis of natural α-glucosidase inhibitors from flavonoids of Radix scutellariae using ultrafiltration UPLC-TripleTOF-MS/MS and network pharmacology
title_full A systematic analysis of natural α-glucosidase inhibitors from flavonoids of Radix scutellariae using ultrafiltration UPLC-TripleTOF-MS/MS and network pharmacology
title_fullStr A systematic analysis of natural α-glucosidase inhibitors from flavonoids of Radix scutellariae using ultrafiltration UPLC-TripleTOF-MS/MS and network pharmacology
title_full_unstemmed A systematic analysis of natural α-glucosidase inhibitors from flavonoids of Radix scutellariae using ultrafiltration UPLC-TripleTOF-MS/MS and network pharmacology
title_short A systematic analysis of natural α-glucosidase inhibitors from flavonoids of Radix scutellariae using ultrafiltration UPLC-TripleTOF-MS/MS and network pharmacology
title_sort systematic analysis of natural α glucosidase inhibitors from flavonoids of radix scutellariae using ultrafiltration uplc tripletof ms ms and network pharmacology
topic Radix scutellariae
Flavonoids
α-Glucosidase inhibitors
Ultrafiltration
LC-MS
Network pharmacology
url http://link.springer.com/article/10.1186/s12906-020-2871-3
work_keys_str_mv AT lewang asystematicanalysisofnaturalaglucosidaseinhibitorsfromflavonoidsofradixscutellariaeusingultrafiltrationuplctripletofmsmsandnetworkpharmacology
AT nanatan asystematicanalysisofnaturalaglucosidaseinhibitorsfromflavonoidsofradixscutellariaeusingultrafiltrationuplctripletofmsmsandnetworkpharmacology
AT huanwang asystematicanalysisofnaturalaglucosidaseinhibitorsfromflavonoidsofradixscutellariaeusingultrafiltrationuplctripletofmsmsandnetworkpharmacology
AT jingbohu asystematicanalysisofnaturalaglucosidaseinhibitorsfromflavonoidsofradixscutellariaeusingultrafiltrationuplctripletofmsmsandnetworkpharmacology
AT wenbodiwu asystematicanalysisofnaturalaglucosidaseinhibitorsfromflavonoidsofradixscutellariaeusingultrafiltrationuplctripletofmsmsandnetworkpharmacology
AT xiaolingwang asystematicanalysisofnaturalaglucosidaseinhibitorsfromflavonoidsofradixscutellariaeusingultrafiltrationuplctripletofmsmsandnetworkpharmacology
AT lewang systematicanalysisofnaturalaglucosidaseinhibitorsfromflavonoidsofradixscutellariaeusingultrafiltrationuplctripletofmsmsandnetworkpharmacology
AT nanatan systematicanalysisofnaturalaglucosidaseinhibitorsfromflavonoidsofradixscutellariaeusingultrafiltrationuplctripletofmsmsandnetworkpharmacology
AT huanwang systematicanalysisofnaturalaglucosidaseinhibitorsfromflavonoidsofradixscutellariaeusingultrafiltrationuplctripletofmsmsandnetworkpharmacology
AT jingbohu systematicanalysisofnaturalaglucosidaseinhibitorsfromflavonoidsofradixscutellariaeusingultrafiltrationuplctripletofmsmsandnetworkpharmacology
AT wenbodiwu systematicanalysisofnaturalaglucosidaseinhibitorsfromflavonoidsofradixscutellariaeusingultrafiltrationuplctripletofmsmsandnetworkpharmacology
AT xiaolingwang systematicanalysisofnaturalaglucosidaseinhibitorsfromflavonoidsofradixscutellariaeusingultrafiltrationuplctripletofmsmsandnetworkpharmacology